Given that several studies (58, 59) suggest that KRAS overexpression also induces ROS production, KRAS-mediated ROS generation may also contribute to the KRAS mutation–driven platinum resistance in NSCLC cells. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.